Understanding injectable MAT options
If you are exploring long acting injectable opioid dependency treatment options, you’ll find extended-release formulations such as Sublocade and Vivitrol designed to support your recovery journey. These monthly injections deliver medication steadily over weeks, reducing daily dosing and helping you focus on healing. Both treatments fall under medications for opioid use disorder (MAT), offering clinically validated approaches to maintenance therapy and relapse prevention.
What are extended-release injections?
Extended-release injections refer to subcutaneous or intramuscular formulations that release medication gradually over an extended period. Unlike daily oral medications, these therapies ensure stable blood concentrations, reducing peaks and troughs that can trigger cravings or side effects. Because they require administration by a qualified provider, injectable MAT delivers consistent dosing and supports adherence for anyone who may face challenges with daily pill routines.
How Sublocade works
Sublocade is a monthly extended-release buprenorphine injection administered subcutaneously in the abdominal area. After initial stabilization on sublingual buprenorphine, you receive a 300 mg injection in month one, followed by 100 mg or 300 mg monthly doses as prescribed. The depot formulation forms a small implant under the skin that steadily releases buprenorphine, a partial opioid agonist, helping you manage withdrawal symptoms and cravings without daily dosing. Depot buprenorphine formulations like Sublocade have been available since April 2020 [1].
How Vivitrol works
Vivitrol is an extended-release naltrexone injection given intramuscularly in the gluteal muscle once a month. Naltrexone is an opioid antagonist, blocking opioid receptors and reducing the euphoric effects of opioids. Before starting Vivitrol, you must complete an opioid detox and remain opioid-free for at least 7 to 10 days to avoid precipitated withdrawal. After the initial 380 mg injection, subsequent monthly doses maintain receptor blockade, which helps prevent relapse for opioid use disorder and supports alcohol relapse prevention [2].
Exploring treatment benefits
When you choose a monthly injectable therapy, you gain several advantages over daily oral regimens. Below are the key benefits you can expect from these long acting options.
Steady medication levels
- Ensures consistent plasma concentration, reducing cravings and withdrawal symptoms
- Minimizes peaks and troughs that can contribute to lapse or side effects
- Enhances medication bioavailability compared to variable oral absorption
By maintaining stable drug levels, you stay in a therapeutic window that fosters recovery without the stress of daily dosing decisions.
Reduced administration burden
- One clinic visit per month for injection, instead of daily pill reminders
- Simplifies your recovery routine and reduces stigma associated with daily medication
- Frees up mental energy to focus on therapy, work, and personal goals
The reduced burden supports you in maintaining a structured plan, especially when juggling multiple responsibilities.
Lower relapse risk
Long acting injectables minimize opportunities for missed doses or diversion, which can lead to relapse. Evidence shows that sustained-release formulations can lead to better retention in treatment compared to oral or daily alternatives. With fewer dosing interruptions, you lower your risk of withdrawal-driven relapse.
Comparing key features
Choosing between Sublocade and Vivitrol depends on your treatment goals, medical history, and personal preferences. The table below summarizes the core features of each option.
| Feature | Sublocade | Vivitrol |
|---|---|---|
| Mechanism | Partial opioid agonist (buprenorphine) | Opioid antagonist (naltrexone) |
| Dosing schedule | Monthly subcutaneous injection | Monthly intramuscular injection |
| Treatment indication | Opioid use disorder maintenance | Opioid relapse prevention and alcohol relapse prevention |
| Administration site | Abdomen | Gluteal muscle |
| Initiation requirements | Stabilization on sublingual buprenorphine | Must be opioid-free for 7–10 days |
| Risk management | REMS program participation | No REMS requirement |
| Internal link | monthly sublocade treatment program | vivitrol program outpatient clinic |
Eligibility and indications
Sublocade is indicated for adults with moderate to severe opioid use disorder who have achieved initial stabilization on transmucosal buprenorphine. By contrast, Vivitrol is approved for preventing relapse to opioid dependence after detox and for treating alcohol use disorder. Discuss with your provider which indication matches your recovery needs.
Side effect profiles
Both injectables are generally well tolerated, but you may experience:
- Sublocade: injection site pain, headache, nausea, fatigue
- Vivitrol: injection site reactions, nausea, dizziness, anxiety
Your provider will monitor side effects and adjust treatment as needed to ensure you remain comfortable and safe.
Addressing common concerns
You may have questions or hesitations about injectable MAT. Below are three frequent concerns and evidence-based insights to help you decide.
“Replacing one drug with another” myth
About 40% of participants in one survey viewed medications for opioid use disorder as a “band-aid” solution or financial gain for pharmaceutical companies [2]. In reality, MOUD reduces overdose risk, stabilizes daily functioning, and supports long-term recovery. Buprenorphine and naltrexone have been shown to lower health problems associated with injecting opioids and decrease the likelihood of relapse.
Safety of long-term use
Medications like buprenorphine, methadone, and naltrexone are safe for long-term use and can be continued for months or years as needed [3]. Extended-release formulations further improve safety by reducing diversion and ensuring proper dosing under medical supervision.
Injection versus oral hesitations
You might worry about injection-related discomfort or logistics. Modern formulations use fine-gauge needles and local anesthetic techniques to minimize pain. Controlled clinic environments ensure proper administration, reducing risks of improper absorption. Many find that the convenience and consistency outweigh brief injection-site discomfort.
Navigating insurance coverage
Understanding insurance benefits is crucial for accessing injectable MAT. Many plans cover both Sublocade and Vivitrol, but requirements vary. Below are key considerations and resources to verify your benefits.
Vivitrol insurance details
Most commercial and government plans cover monthly Vivitrol injections under medical benefits. You can verify coverage for your insurance covered vivitrol injection and explore substance use vivitrol program coverage. Prior authorization may be required, but your care team can assist you in securing approvals and minimizing out-of-pocket costs.
Sublocade coverage support
Sublocade is covered under many pharmacy and medical benefit plans. To confirm your benefits, use our sublocade insurance verification support tool. If you have Medicaid, you may qualify for sublocade appointment covered by medicaid. Our staff works directly with your insurer to secure approvals and coordinate shipment to your provider.
Medicaid and telehealth options
If you rely on Medicaid or prefer remote care, explore our insurance verified injectable mat program. Telehealth follow-up visits can be arranged through telehealth sublocade appointment setup or vivitrol treatment with telehealth follow up, reducing travel time and ensuring continuity of care.
Integrating therapy support
Medication is most effective when paired with comprehensive therapy. At Carolina Energetics, we emphasize integrated care to help you address underlying factors that contribute to substance use.
Medication and counseling
Combining injectable MAT with therapy enhances outcomes. Learn about our sublocade and counseling integration services, which include individual and group sessions rooted in cognitive behavioral therapy and motivational interviewing. For Vivitrol, consider pairing injections with vivitrol and relapse prevention services to build coping skills and support networks.
Telehealth follow-up
Regular check-ins via telehealth ensure you receive ongoing support without extra commute. Our telehealth sublocade appointment setup and vivitrol treatment with telehealth follow up services allow you to discuss progress, address side effects, and adjust your plan as needed. Virtual visits are secure, HIPAA-compliant, and convenient.
Local program resources
To find a nearby injection site, use our sublocade treatment provider near me locator. In North Carolina, explore specialized support through our vivitrol therapy program north carolina. Whether you choose outpatient or inpatient care, our network connects you with clinicians trained in injectable therapies.
Getting started guide
Initiating injectable MAT can feel daunting. Follow these steps to prepare and feel confident about your first appointment.
Preparing for treatment
- Confirm detox status (for Vivitrol) and stabilization on sublingual buprenorphine (for Sublocade)
- Collect medical records, including prescription history and lab results
- Review your current medications and allergies
- Arrange transportation and schedule time off work if needed
- Identify a support person for appointments and follow-up calls
First injection appointment
- Pre-assessment: Review your medical history, vital signs, and treatment goals
- Baseline labs: Complete liver function tests, pregnancy tests, and other screenings
- Dosing plan: Confirm your injection schedule and dosage
- Administration: Receive your first dose under medical supervision
- Follow-up planning: Schedule your next appointment and access sublocade injection treatment assistance or vivitrol medication management plan
Ongoing monitoring
- Monthly visits: Adhere to your injection schedule and update your care plan
- Side effect check: Report any injection site reactions or systemic effects
- Dosage adjustments: Your provider may modify dosing based on progress
- Support resources: Engage in peer groups, telehealth check-ins, and counseling to stay motivated
Sustaining long-term recovery
Long acting injectable therapies are powerful tools, but lasting recovery depends on a holistic approach. By combining medication, therapy, peer support, and individualized planning, you create a foundation for sustained wellness.
Consider these strategies to maintain progress:
- Track your adherence and withdrawal symptoms with validated scales
- Engage regularly in peer support groups or 12-step meetings
- Practice coping strategies learned in therapy, such as mindfulness or stress management
- Build healthy routines around nutrition, exercise, and sleep
- Schedule periodic reviews with your provider to adjust your plan as needed
At Carolina Energetics, our team supports your journey with medication management, insurance assistance, integrated counseling, and both in-person and telehealth options. If you’re ready to explore monthly injectable treatments, verify your coverage and schedule a consultation today. Our experts will guide you through each step, ensuring you have the tools and support necessary for lasting recovery.
